Gerson and Ferrucci talk retina pipeline

Video
Conference|Vision Expo West

Optometry Times® Editorial Advisory Board members Jeffry Gerson, OD, FAAO; and Steven Ferrucci, OD, FAAO, chat about what’s new in the retina space while at Vision Expo West 2021 in Las Vegas.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Devin Sasser, OD, shares his excitement for Acuvue Oasys MAX 1-Day multifocal for astigmatism, the first and only daily disposable multifocal toric contact lens.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
Ashley Mills, CEO of The Vision Council, gives insight into the decision to move to a single annual meeting and shares the vision for the meeting going forward.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
At CIME 2025, Selina McGee, OD, FAAO, says some patients underestimate oculoplastic care. She stands in front of a sign that says Controversies in Modern Eye Care 2025.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
Dr. Mile Brujic discusses a case series on a novel gel for lacrimal occlusion.
Steven T. Reed, OD, talks Optometry's Meeting and public-facing initiatives that optometrists can take advantage of.
Related Content
Santen begins European rollout of low-dose atropine for myopia in Germany - Image credit: ©Christian Müller—stock.adobe.com

Santen begins European rollout of low-dose atropine for myopia in Germany

Emily Kaiser Maharjan, Assistant Managing Editor
July 22nd 2025
Article
Practical management EP 14: Your practice-purchase checklist

Practical management EP 14: Your practice-purchase checklist

Maria Sampalis, OD;Kassi Filkins, Editor
April 27th 2023
Podcast
FDA accepts Aldeyra Therapeutics' new drug application for reproxalap for review.

FDA accepts for review Aldeyra Therapeutics’ resubmitted new drug application for reproxalap

Martin David Harp, Editor, Ophthalmology Times
July 17th 2025
Article
Jill Saxon, OD, executive director of professional strategy at Bausch + Lomb

Community care: Connecting mentorship and representation

Emily Kaiser Maharjan, Assistant Managing Editor
April 26th 2023
Podcast
AOA 2025 In vitro antioxidant effects of dry eye formulation on human corneal epithelial cells - Image credit: ©Gevorg Simonyan—stock.adobe.com

AOA 2025: In vitro antioxidant effects of dry eye formulation on human corneal epithelial cells

Lynda Charters
June 28th 2025
Article
AOA 2025: Lifitegrast 5.0% shows positive effect on clinical signs and biomarkers in patients with dry eye disease - Image credit: ©Andrey Nikitin—stcok.adobe.com

AOA 2025: Lifitegrast 5.0% shows positive effect on clinical signs and biomarkers in patients with dry eye disease

Lynda Charters
June 26th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.